MedPath
HSA Product

Quetiapine Sandoz 100 mg Tablets

Product approved by Health Sciences Authority (SG)

Basic Information

Quetiapine Sandoz 100 mg Tablets

TABLET, FILM COATED

Regulatory Information

SIN13839P

July 26, 2010

Prescription Only

Therapeutic

ORAL

August 10, 2023

June 3, 2025

XN05AH04

Company Information

NOVARTIS (SINGAPORE) PTE LTD

SANDOZ SINGAPORE PTE. LTD.

Active Ingredients

Detailed Information

Contraindications

**4.3 Contraindications** Hypersensitivity to the active substance or to any of the excipients of this product.

Indication Information

**4.1 Therapeutic indications** - Treatment of schizophrenia. - Treatment of acute manic episodes associated with bipolar I disorder. - Treatment of depressive episodes associated with bipolar disorder. - Preventing recurrence in maintenance treatment of bipolar I disorder (manic, mixed or depressive episode) as monotherapy or in combination with lithium or valproate.

© Copyright 2025. All Rights Reserved by MedPath